1. Home
  2. PKOH vs PHAT Comparison

PKOH vs PHAT Comparison

Compare PKOH & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKOH
  • PHAT
  • Stock Information
  • Founded
  • PKOH 1907
  • PHAT 2018
  • Country
  • PKOH United States
  • PHAT United States
  • Employees
  • PKOH N/A
  • PHAT N/A
  • Industry
  • PKOH Industrial Specialties
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKOH Industrials
  • PHAT Health Care
  • Exchange
  • PKOH Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • PKOH 397.8M
  • PHAT 465.0M
  • IPO Year
  • PKOH N/A
  • PHAT 2019
  • Fundamental
  • Price
  • PKOH $24.95
  • PHAT $6.96
  • Analyst Decision
  • PKOH
  • PHAT Strong Buy
  • Analyst Count
  • PKOH 0
  • PHAT 4
  • Target Price
  • PKOH N/A
  • PHAT $23.00
  • AVG Volume (30 Days)
  • PKOH 30.7K
  • PHAT 971.9K
  • Earning Date
  • PKOH 03-04-2025
  • PHAT 03-06-2025
  • Dividend Yield
  • PKOH 2.00%
  • PHAT N/A
  • EPS Growth
  • PKOH N/A
  • PHAT N/A
  • EPS
  • PKOH 1.29
  • PHAT N/A
  • Revenue
  • PKOH $1,657,100,000.00
  • PHAT $26,270,000.00
  • Revenue This Year
  • PKOH $2.85
  • PHAT $7,622.43
  • Revenue Next Year
  • PKOH $4.63
  • PHAT $236.87
  • P/E Ratio
  • PKOH $7.45
  • PHAT N/A
  • Revenue Growth
  • PKOH 0.31
  • PHAT N/A
  • 52 Week Low
  • PKOH $22.74
  • PHAT $6.07
  • 52 Week High
  • PKOH $34.50
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • PKOH 37.83
  • PHAT 37.02
  • Support Level
  • PKOH $23.04
  • PHAT $6.36
  • Resistance Level
  • PKOH $25.46
  • PHAT $7.20
  • Average True Range (ATR)
  • PKOH 0.88
  • PHAT 0.48
  • MACD
  • PKOH 0.16
  • PHAT 0.08
  • Stochastic Oscillator
  • PKOH 44.84
  • PHAT 30.48

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: